Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

Simpson, GR, Horvath, A, Annels, NE et al. (10 more authors) (2012) Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer. British Journal of Cancer, 106. pp. 496-507. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Simpson, GR
  • Horvath, A
  • Annels, NE
  • Pencavel, T
  • Metcalf, S
  • Seth, R
  • Peschard, P
  • Price, T
  • Coffin, RS
  • Mostafid, H
  • Melcher, AA
  • Harrington, KJ
  • Pandha, HS
Copyright, Publisher and Additional Information: (c) 2012, Cancer Research UK. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: Oncolytic HSV; Bladder cancer; Micro CT; Orthotopic model; Fusogenic glycoprotein; Prodrug therapy
Dates:
  • Published: 31 January 2012
  • Accepted: 1 December 2011
  • Published (online): 12 January 2012
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Oncology and Cancer Research - Labs (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 25 Aug 2016 15:13
Last Modified: 01 Mar 2019 11:49
Published Version: http://dx.doi.org/10.1038/bjc.2011.577
Status: Published
Publisher: Cancer Research UK
Identification Number: https://doi.org/10.1038/bjc.2011.577
Related URLs:

Share / Export

Statistics